Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SDC, a specialized data services Contract Research Organization (CRO) providing scalable clinical trial solutions, has opened a new office in Waltham, Mass. Fueled by accelerated growth and continued high demand for its services, SDC’s strategic ...
read more
Thursday, November 08, 2012
SCYNEXIS, Inc. today announced that the results of a Phase 2a study of lead candidate SCY-635 for the treatment of the hepatitis C virus (HCV) will be the subject of an oral presentation at the 63rd Annual Meeting of the American Association for the ...
read more
SCYNEXIS, Inc. announced today that Merck, known as MSD outside the United States and Canada, has decided to return to SCYNEXIS all development and commercialization rights for the novel antifungal compound, MK-3118, an oral glucan synthase inhibitor...
read more
Thursday, February 18, 2021
SCYNEXIS has entered into a licensing agreement and strategic partnership with Hansoh Pharmaceutical Group.
read more
SCYNEXIS, Inc. announced today that Immune Design Corp. has selected SCYNEXIS as its chemical development and cGMP production partner for manufacture of Glucopyranosyl Lipid A (GLA).
read more
The Scripps Research Institute and ShangPharma Innovation announced a collaboration to accelerate the development of drug candidates through scientific collaboration, a services relationship with Shanghai ChemPartner, and sponsored research at TSRI ...
read more
Professor Matthew Disney of TSRI, scientists from Mayo Clinic’s Florida campus and Johns Hopkins School of Medicine, have been awarded $7.2 million for the most common form of ALS and FTD.
read more
Thursday, September 20, 2018
SCOUT has formed a joint venture with Rare Expertise, a company with proprietary data-driven tools for identifying and activating people with rare disorders.
read more
Friday, February 17, 2017
SYMBIOSIS Pharmaceutical Services is set to open an office in North America in response to continued demand from US-based biotechnology companies for its vial-filling expertise.
read more
Pharmaceutical and biopharmaceutical companies that outsource manufacturing see their relationship with manufacturers differently than do CDMOs and CMOs.
read more
Friday, November 20, 2015
SCORR Marketing has published a report that presents a detailed analysis of websites of leading contract research organizations (CROs) and contract manufacturing organizations (CMOs).
read more
Wednesday, March 29, 2023
Scorpius BioManufacturing, a Texas-based biologics contract research and contract development & manufacturing organization (CDMO), announced the appointment of Gary Welch as Interim President.
read more
Scorpius BioManufacturing, a Texas-based biologics contract development and manufacturing organization (CDMO), announced the appointment of Joe Payne as Vice President, Quality and Regulatory Affairs.
read more
Wednesday, March 22, 2023
Scorpius BioManufacturing announced the appointment of Gary Welch as Interim President. With a career spanning more than 30 years in biopharmaceuticals at large manufacturers like AbbVie and biotech innovators like Agensys and CytomX, Gary will lead ...
read more
Thursday, November 07, 2024
Scorpius Holdings, Inc. announced a partnership with Celltheon Corporation to provide cell line development services to clients using Celltheon’s proprietary GOLDILOCKS™ transposase-based platform.
read more